Slideshow: BrainArt
15 October, 2012 by Staff WritersThe BrainArt Exhibition integrates the artistic and scientific worlds, depicting the application of neuroscience in our daily lives.
Co-opting a killer virus peptide to combat cancer
08 October, 2012 by Tim DeanA team at RMIT has used an advanced new technique to synthesise a key peptide from the myxoma virus that is responsible for its cancer killing clout, and have found this peptide can do its dirty work without harming healthy cells
AHG’s CardioCel receives special access approval from TGA
26 September, 2012 by Dylan Bushell-EmblingAllied Healthcare has had a win in the step to see its congenital heart defect treatment, CardioCel, approved for use across Australia.
Chris Goodnow receives GSK Award for pioneering autoimmune research
12 September, 2012 by Tim DeanProfessor Chris Goodnow has received the $80,000 GlaxoSmithKline Award for Research Excellence which will fund his research into a controversial theory on the origin of autoimmune diseases.
Science in the blood: L’Oreal Fellowship awarded to WEHI’s Kylie Mason
21 August, 2012 by Tim DeanOne of the three L’Oreal Fellowships has been awarded to Dr Kylie Mason for her work understanding the relationship between cancer and blood.
Epigenetics discovery aids prostate cancer diagnosis
07 August, 2012 by Tim DeanThe discovery of a microRNA that appears to affect prostate cancer proliferation and metastasis could prove a valuable biomarker for diagnosis.
Gardasil vaccine may offer protection from prostate cancer
02 August, 2012 by Staff WritersVaccinating young males against human papilloma virus might not only slow the spread of the virus and cervical cancer in women, but may also help protect men from prostate cancer.
Opinion: Catch cancer? No thanks, I’d rather have a shot!
10 July, 2012 by Staff WritersVaccines for the cancers we know or suspect may be linked to viruses should be possible. We know how to do the work. All it will take is funding to support the research scientists working on these vaccines, and time, says Professor Ian Frazer.
Feature: Moving target
09 July, 2012 by Fiona WylieProfessor Johnson Mak is working to understand how HIV functions with the hope of revealing weaknesses that could enable effective treatments and vaccines.
Gene muscles in on Type 2 diabetes
29 May, 2012 by Tim DeanScientists have discovered a gene that appears to regulate muscle development and size. Tweaking it could help treat Type 2 diabetes.
Turning the immune system on cancer
25 May, 2012 by Tim DeanResearchers from Western Australia have produced a targeted version of a natural protein that can open up cancerous tumours to attack by the body’s own immune system.
Combination therapy protects the brain from malaria infection
24 May, 2012 by Tim DeanAdding a new anti-inflammatory drug to conventional malaria treatments may help prevent irrevocable brain damage associated with cerebral malaria.
GTG breast cancer test sales gaining pace in US
22 May, 2012 by Dylan Bushell-EmblingMelbourne's Genetic Technologies (ASX:GTG) has revealed that its genetic test for breast cancer risk, BREVAGen, is gaining traction in the US.
Bioniche developing cancer products for dogs
03 May, 2012 by Dylan Bushell-EmblingBioniche (ASX:BNC) is commercialising two products designed to treat cancer in man's best friend, including an immunotherapy for mammary cancer.
Feature: Skin deep
01 May, 2012 by Fiona WylieSkin cells are constantly generating and differentiating throughout our lives. Professor Fiona Watt is uncovering how stem cells in the skin perform these remarkable feats, and how they can sometimes go awry.
